Urine Test Could Catch Pancreatic Cancer Sooner.
Researchers have uncovered a biomarker for pancreatic cancer that can be detected in urine samples. The discovery may pave the way for a low-cost, noninvasive test that could detect the disease in its earlier stages. Currently, early diagnosis of pancreatic cancer is uncommon, with approximately 80% of patients being diagnosed at later stages. Lead researcher Dr. Tatjana Crnogorac-Jurcevic explains, “We’ve always been keen to develop a diagnostic test in urine as it has several advantages over using blood. It’s an inert and far less complex fluid than blood and can be repeatedly and noninvasively tested… This is a biomarker panel with good specificity and sensitivity and we’re hopeful that a simple, inexpensive test can be developed and be in clinical use within the next few years.”
Clinical Cancer Research, August 2015